The baseline characteristics did not differ significantly between these two groups, including age, tumor location, and tumor grade; however, there were higher percentages of advanced tumor stage and adjuvant treatment in the SDF-1α overexpression group (Table 2). Here, CXCL12 is linked to neoplasm.